File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: Dose response and safety of the daily, oral RIG-I agonist Inarigivir (SB 9200) in treatment naïve patients with chronic hepatitis B: results from the 25mg and 50mg cohorts in the ACHIEVE trial

TitleDose response and safety of the daily, oral RIG-I agonist Inarigivir (SB 9200) in treatment naïve patients with chronic hepatitis B: results from the 25mg and 50mg cohorts in the ACHIEVE trial
Authors
Issue Date2018
PublisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhep
Citation
The International Liver Congress 2018, Paris, France, 11-15 April 2018. In Journal of Hepatology, 2018, v. 68 n. Suppl. 1, p. S509-S510 How to Cite?
DescriptionPoster Presentation - no. FRI-327
Persistent Identifierhttp://hdl.handle.net/10722/264590
ISSN
2017 Impact Factor: 15.04
2015 SCImago Journal Rankings: 4.570

 

DC FieldValueLanguage
dc.contributor.authorYuen, RMF-
dc.contributor.authorElkashab, M-
dc.contributor.authorChen, CY-
dc.contributor.authorCoffin, C-
dc.contributor.authorFung, S-
dc.contributor.authorGreenbloom, S-
dc.contributor.authorJang, JW-
dc.contributor.authorJeng, RWJ-
dc.contributor.authorKim, DJ-
dc.contributor.authorKim, YJ-
dc.contributor.authorKim, W-
dc.contributor.authorLee, KS-
dc.contributor.authorLim, YS-
dc.contributor.authorRamji, A-
dc.contributor.authorIyer, R-
dc.contributor.authorMacfarlane, C-
dc.contributor.authorJackson, K-
dc.contributor.authorLocarnini, S-
dc.contributor.authorAfdhal, N-
dc.contributor.authorChan, H-
dc.date.accessioned2018-10-22T07:57:28Z-
dc.date.available2018-10-22T07:57:28Z-
dc.date.issued2018-
dc.identifier.citationThe International Liver Congress 2018, Paris, France, 11-15 April 2018. In Journal of Hepatology, 2018, v. 68 n. Suppl. 1, p. S509-S510-
dc.identifier.issn0168-8278-
dc.identifier.urihttp://hdl.handle.net/10722/264590-
dc.descriptionPoster Presentation - no. FRI-327-
dc.languageeng-
dc.publisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhep-
dc.relation.ispartofJournal of Hepatology-
dc.relation.ispartofThe International Liver Congress 2018-
dc.titleDose response and safety of the daily, oral RIG-I agonist Inarigivir (SB 9200) in treatment naïve patients with chronic hepatitis B: results from the 25mg and 50mg cohorts in the ACHIEVE trial-
dc.typeConference_Paper-
dc.identifier.emailYuen, RMF: mfyuen@hku.hk-
dc.identifier.authorityYuen, RMF=rp00479-
dc.identifier.doi10.1016/S0168-8278(18)31267-4-
dc.identifier.hkuros293851-
dc.identifier.volume68-
dc.identifier.issueSuppl. 1-
dc.identifier.spageS509-
dc.identifier.epageS510-
dc.publisher.placeNetherlands-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats